John A. Galloway, MD, FACP: A Pharmaceutical Physician and Leader in Diabetes Therapy
Anderson profiles John A. Galloway, pharmaceutical physician and leader in diabetes therapy. Galloway has been that leader, whose clinical curiosity, insights, dedication, and commitment to others brought insulin therapy from the impurified, low-potency animal insulins to the modern insulins of toda...
Gespeichert in:
| Veröffentlicht in: | Diabetes care 2018-12, Vol.41 (12), p.2448-2452 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2452 |
|---|---|
| container_issue | 12 |
| container_start_page | 2448 |
| container_title | Diabetes care |
| container_volume | 41 |
| creator | Anderson, James H |
| description | Anderson profiles John A. Galloway, pharmaceutical physician and leader in diabetes therapy. Galloway has been that leader, whose clinical curiosity, insights, dedication, and commitment to others brought insulin therapy from the impurified, low-potency animal insulins to the modern insulins of today. Born in Omaha, Nebraska, in 1928, Galloway moved to Washington, DC, and graduated from St. Albans School in 1946 and then from the University of Pennsylvania in Philadelphia in 1950 with a BA in English and Pre-Med. Galloway became Director of Clinical Diabetes at the Lilly Clinic (Lilly Laboratories for Clinical Research), then located at Wishard Memorial Hospital on the campus of the Indiana University School of Medicine, where he was appointed Associate Professor. |
| doi_str_mv | 10.2337/dci18-0042 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2136558273</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2136558273</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-95a8666cf6deeac80c688dc6bf8289bd82bc602902dc687af6f02b6219720e7e3</originalsourceid><addsrcrecordid>eNpd0E1LwzAYwPEgipvTix9AAl5E1pmXJk28lc1NZeIO27mkacoqfZlJi_Tbm7npwVN4wo-Hhz8A1xhNCKXRQ6YLLAKEQnIChlhSFjAWilMwRDiUAZOSDMCFcx_Ik1CIczCgKGSShHwINq_NtobxBC5UWTZfqh_Dt9kYzuPp6hHGcLVVtlLadG2hVenH3hW6UDVUdQaXRmXGwqKGs0KlpjUOrrfGql1_Cc5yVTpzdXxHYDN_Wk-fg-X74mUaLwNNMWoDyZTgnOucZ8YoLZDmQmSap7kgQqaZIKnmiEhE_KeIVM5zRFJOsIwIMpGhI3B32LuzzWdnXJtUhdOmLFVtms4lBFPOmCAR9fT2H_1oOlv767xiYeRTidCr-4PStnHOmjzZ2aJStk8wSvaxk5_YyT62xzfHlV1ameyP_tal3xHSdq0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2154714984</pqid></control><display><type>article</type><title>John A. Galloway, MD, FACP: A Pharmaceutical Physician and Leader in Diabetes Therapy</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Anderson, James H</creator><creatorcontrib>Anderson, James H</creatorcontrib><description>Anderson profiles John A. Galloway, pharmaceutical physician and leader in diabetes therapy. Galloway has been that leader, whose clinical curiosity, insights, dedication, and commitment to others brought insulin therapy from the impurified, low-potency animal insulins to the modern insulins of today. Born in Omaha, Nebraska, in 1928, Galloway moved to Washington, DC, and graduated from St. Albans School in 1946 and then from the University of Pennsylvania in Philadelphia in 1950 with a BA in English and Pre-Med. Galloway became Director of Clinical Diabetes at the Lilly Clinic (Lilly Laboratories for Clinical Research), then located at Wishard Memorial Hospital on the campus of the Indiana University School of Medicine, where he was appointed Associate Professor.</description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/dci18-0042</identifier><identifier>PMID: 30459246</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>Colleges & universities ; Diabetes ; Diabetes mellitus ; Galloway, John A ; Insulin ; Laboratories ; Personal profiles ; Pharmaceuticals ; Physicians ; Therapy</subject><ispartof>Diabetes care, 2018-12, Vol.41 (12), p.2448-2452</ispartof><rights>Copyright American Diabetes Association Dec 1, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c310t-95a8666cf6deeac80c688dc6bf8289bd82bc602902dc687af6f02b6219720e7e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30459246$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anderson, James H</creatorcontrib><title>John A. Galloway, MD, FACP: A Pharmaceutical Physician and Leader in Diabetes Therapy</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description>Anderson profiles John A. Galloway, pharmaceutical physician and leader in diabetes therapy. Galloway has been that leader, whose clinical curiosity, insights, dedication, and commitment to others brought insulin therapy from the impurified, low-potency animal insulins to the modern insulins of today. Born in Omaha, Nebraska, in 1928, Galloway moved to Washington, DC, and graduated from St. Albans School in 1946 and then from the University of Pennsylvania in Philadelphia in 1950 with a BA in English and Pre-Med. Galloway became Director of Clinical Diabetes at the Lilly Clinic (Lilly Laboratories for Clinical Research), then located at Wishard Memorial Hospital on the campus of the Indiana University School of Medicine, where he was appointed Associate Professor.</description><subject>Colleges & universities</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Galloway, John A</subject><subject>Insulin</subject><subject>Laboratories</subject><subject>Personal profiles</subject><subject>Pharmaceuticals</subject><subject>Physicians</subject><subject>Therapy</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpd0E1LwzAYwPEgipvTix9AAl5E1pmXJk28lc1NZeIO27mkacoqfZlJi_Tbm7npwVN4wo-Hhz8A1xhNCKXRQ6YLLAKEQnIChlhSFjAWilMwRDiUAZOSDMCFcx_Ik1CIczCgKGSShHwINq_NtobxBC5UWTZfqh_Dt9kYzuPp6hHGcLVVtlLadG2hVenH3hW6UDVUdQaXRmXGwqKGs0KlpjUOrrfGql1_Cc5yVTpzdXxHYDN_Wk-fg-X74mUaLwNNMWoDyZTgnOucZ8YoLZDmQmSap7kgQqaZIKnmiEhE_KeIVM5zRFJOsIwIMpGhI3B32LuzzWdnXJtUhdOmLFVtms4lBFPOmCAR9fT2H_1oOlv767xiYeRTidCr-4PStnHOmjzZ2aJStk8wSvaxk5_YyT62xzfHlV1ameyP_tal3xHSdq0</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Anderson, James H</creator><general>American Diabetes Association</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201812</creationdate><title>John A. Galloway, MD, FACP: A Pharmaceutical Physician and Leader in Diabetes Therapy</title><author>Anderson, James H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-95a8666cf6deeac80c688dc6bf8289bd82bc602902dc687af6f02b6219720e7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Colleges & universities</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Galloway, John A</topic><topic>Insulin</topic><topic>Laboratories</topic><topic>Personal profiles</topic><topic>Pharmaceuticals</topic><topic>Physicians</topic><topic>Therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anderson, James H</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anderson, James H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>John A. Galloway, MD, FACP: A Pharmaceutical Physician and Leader in Diabetes Therapy</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2018-12</date><risdate>2018</risdate><volume>41</volume><issue>12</issue><spage>2448</spage><epage>2452</epage><pages>2448-2452</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><abstract>Anderson profiles John A. Galloway, pharmaceutical physician and leader in diabetes therapy. Galloway has been that leader, whose clinical curiosity, insights, dedication, and commitment to others brought insulin therapy from the impurified, low-potency animal insulins to the modern insulins of today. Born in Omaha, Nebraska, in 1928, Galloway moved to Washington, DC, and graduated from St. Albans School in 1946 and then from the University of Pennsylvania in Philadelphia in 1950 with a BA in English and Pre-Med. Galloway became Director of Clinical Diabetes at the Lilly Clinic (Lilly Laboratories for Clinical Research), then located at Wishard Memorial Hospital on the campus of the Indiana University School of Medicine, where he was appointed Associate Professor.</abstract><cop>United States</cop><pub>American Diabetes Association</pub><pmid>30459246</pmid><doi>10.2337/dci18-0042</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0149-5992 |
| ispartof | Diabetes care, 2018-12, Vol.41 (12), p.2448-2452 |
| issn | 0149-5992 1935-5548 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2136558273 |
| source | EZB-FREE-00999 freely available EZB journals |
| subjects | Colleges & universities Diabetes Diabetes mellitus Galloway, John A Insulin Laboratories Personal profiles Pharmaceuticals Physicians Therapy |
| title | John A. Galloway, MD, FACP: A Pharmaceutical Physician and Leader in Diabetes Therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T08%3A56%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=John%20A.%20Galloway,%20MD,%20FACP:%20A%20Pharmaceutical%20Physician%20and%20Leader%20in%20Diabetes%20Therapy&rft.jtitle=Diabetes%20care&rft.au=Anderson,%20James%20H&rft.date=2018-12&rft.volume=41&rft.issue=12&rft.spage=2448&rft.epage=2452&rft.pages=2448-2452&rft.issn=0149-5992&rft.eissn=1935-5548&rft_id=info:doi/10.2337/dci18-0042&rft_dat=%3Cproquest_cross%3E2136558273%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2154714984&rft_id=info:pmid/30459246&rfr_iscdi=true |